Matches in SemOpenAlex for { <https://semopenalex.org/work/W176339747> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W176339747 endingPage "72" @default.
- W176339747 startingPage "169" @default.
- W176339747 abstract "One hundred ninety six dogs with spontaneously occurring lymphoproliferative disorders were immunophenotyped. Dogs with lymphoma (175) were determined to be derived from B-cells in 134/175 (76%), T-cells in 38/175 (22%) and 3/175 (2%) were null cells (non-reactive with any canine-specific lymphocyte antibody). Dogs with T-cell lymphomas were at significantly higher risk of relapse and early death compared with B-cell lineage lymphoma following therapy (52 vs. 160 days; p < 0.001 and 153 vs. 330 days; p < 0.001, respectively). Hypercalcemia was associated only with CD4+ lymphomas. A nonimmunoglobulin B-cell marker (B5), expressed in 95% of nonneoplastic lymphocytes, was expressed at a reduced level in 63% (64/104) of dogs with B-cell lymphoma. Dogs with lymphoma in which the B5 antigen was expressed below normal levels experienced shorter progression free survival (125 vs. 202 days; p < 0.05) and overall survival times (203 vs. 385 days; p < 0.05) than dogs with B-cell lymphoma in which the B5 antigen was expressed normally. Chronic lymphocytic leukemia in dogs was primarily associated with a CD8+ phenotype (8/12) and acute lymphoblastic leukemia was determined to be of either null cell (4/9) or T-cell (3/9) phenotype. Although canine and human non-Hodgkin's lymphoma are phenotypically similar, canine leukemia is phenotypically distinct from human leukemia. The development of canine-specific probes has facilitated a priori assessment of treatment outcome in dogs with lymphoma and may in the future contribute to the comparative understanding of leukemo- and lymphoma-genesis in these species." @default.
- W176339747 created "2016-06-24" @default.
- W176339747 creator A5005932889 @default.
- W176339747 creator A5007943482 @default.
- W176339747 creator A5046324927 @default.
- W176339747 creator A5064420100 @default.
- W176339747 creator A5065833147 @default.
- W176339747 date "1997-03-01" @default.
- W176339747 modified "2023-10-10" @default.
- W176339747 title "Immunophenotypic characterization of canine lymphoproliferative disorders." @default.
- W176339747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9179611" @default.
- W176339747 hasPublicationYear "1997" @default.
- W176339747 type Work @default.
- W176339747 sameAs 176339747 @default.
- W176339747 citedByCount "41" @default.
- W176339747 countsByYear W1763397472013 @default.
- W176339747 countsByYear W1763397472014 @default.
- W176339747 countsByYear W1763397472015 @default.
- W176339747 countsByYear W1763397472016 @default.
- W176339747 countsByYear W1763397472017 @default.
- W176339747 countsByYear W1763397472018 @default.
- W176339747 countsByYear W1763397472019 @default.
- W176339747 countsByYear W1763397472021 @default.
- W176339747 countsByYear W1763397472022 @default.
- W176339747 crossrefType "journal-article" @default.
- W176339747 hasAuthorship W176339747A5005932889 @default.
- W176339747 hasAuthorship W176339747A5007943482 @default.
- W176339747 hasAuthorship W176339747A5046324927 @default.
- W176339747 hasAuthorship W176339747A5064420100 @default.
- W176339747 hasAuthorship W176339747A5065833147 @default.
- W176339747 hasConcept C121853132 @default.
- W176339747 hasConcept C142724271 @default.
- W176339747 hasConcept C147483822 @default.
- W176339747 hasConcept C167672396 @default.
- W176339747 hasConcept C194409129 @default.
- W176339747 hasConcept C203014093 @default.
- W176339747 hasConcept C2776995267 @default.
- W176339747 hasConcept C2777761686 @default.
- W176339747 hasConcept C2777938653 @default.
- W176339747 hasConcept C2778461978 @default.
- W176339747 hasConcept C2779338263 @default.
- W176339747 hasConcept C2908752941 @default.
- W176339747 hasConcept C54355233 @default.
- W176339747 hasConcept C71924100 @default.
- W176339747 hasConcept C81885089 @default.
- W176339747 hasConcept C86803240 @default.
- W176339747 hasConceptScore W176339747C121853132 @default.
- W176339747 hasConceptScore W176339747C142724271 @default.
- W176339747 hasConceptScore W176339747C147483822 @default.
- W176339747 hasConceptScore W176339747C167672396 @default.
- W176339747 hasConceptScore W176339747C194409129 @default.
- W176339747 hasConceptScore W176339747C203014093 @default.
- W176339747 hasConceptScore W176339747C2776995267 @default.
- W176339747 hasConceptScore W176339747C2777761686 @default.
- W176339747 hasConceptScore W176339747C2777938653 @default.
- W176339747 hasConceptScore W176339747C2778461978 @default.
- W176339747 hasConceptScore W176339747C2779338263 @default.
- W176339747 hasConceptScore W176339747C2908752941 @default.
- W176339747 hasConceptScore W176339747C54355233 @default.
- W176339747 hasConceptScore W176339747C71924100 @default.
- W176339747 hasConceptScore W176339747C81885089 @default.
- W176339747 hasConceptScore W176339747C86803240 @default.
- W176339747 hasIssue "2" @default.
- W176339747 hasLocation W1763397471 @default.
- W176339747 hasOpenAccess W176339747 @default.
- W176339747 hasPrimaryLocation W1763397471 @default.
- W176339747 hasRelatedWork W176339747 @default.
- W176339747 hasRelatedWork W2012915976 @default.
- W176339747 hasRelatedWork W2030764214 @default.
- W176339747 hasRelatedWork W2069362136 @default.
- W176339747 hasRelatedWork W2085820870 @default.
- W176339747 hasRelatedWork W2109116750 @default.
- W176339747 hasRelatedWork W2148413867 @default.
- W176339747 hasRelatedWork W2330817216 @default.
- W176339747 hasRelatedWork W2435385308 @default.
- W176339747 hasRelatedWork W3173163395 @default.
- W176339747 hasVolume "11" @default.
- W176339747 isParatext "false" @default.
- W176339747 isRetracted "false" @default.
- W176339747 magId "176339747" @default.
- W176339747 workType "article" @default.